The National Medical Products Administration (NMPA) in China has announced the release of the 83rd batch of reference drugs for generic quality consistency evaluation (GQCE) work. This batch includes 49 new specifications and 38 modified specifications, along with updates to the English names of certain drugs and the addition of Marketing Authorization Holders (MAHs). -Fineline Info & Tech
NMPA Expands Generic Quality Consistency Evaluation with 83rd Batch of Reference Drugs
